Skip to main content
. 2023 Mar 13;10:1099840. doi: 10.3389/fmed.2023.1099840

Table 1.

Clinical characteristics according to genetic causes of Bartter syndrome patients.

SLC12A1 (n = 4) KCNJ1 (n = 1) CLCNKB (n = 33) BSND (n = 1) Mutation negative or not available (n = 15) Total (n = 54)
Male: Female (n) 2:2 1:0 18:15 1:0 11:4 33:21
Age of onset (median, month) (range) 11 (0–17) 12 4.5 (0–271) 0 18 (0–111) 5 (0–271)
Perinatal history
Small for GA, % (n) 0 0 11 (3/28) 0 9 (1/11) 9 (4/45)
Preterm infant, % (n) 100 (4) 100 (1) 3 (1/29) 100 (1) 55 (6/11) 28 (13/46)
Polyhydramnios, % (n) 100 (4) 100 (1) 36 (8/22) 100 (1) 40 (4/10) 47 (18/38)
Initial symptom
Failure to thrive, % (n) 50 (2) 100 (1) 76 (25) 100 (1) 27 (4) 6 (33)
Polyuria, % (n) 50 (2) 100 (1) 12 (4) 100 (1) 13 (2) 19 (10)
Lethargy, % (n) 0 100 (1) 12 (4) 0 13 (2) 13 (7)
Muscle cramping, % (n) 0 0 15 (5) 0 13 (2) 13 (7)
Clinical presentation, % (n)
Antenatal BS 24 (1) 100 (1) 30 (10) 100 (1) 20 (3) 30 (16)
Classic BS 75 (3) 0 67 (22) 0 73 (11) 67 (36)
Gitelman-like syndrome 0 0 3 (1) 0 7 (1) 3 (2)
Family history, % (n) 25 (1) 100 (1) 9 (3) 0 13 (2) 13 (7)
eGFR, mean (range), and clinical manifestations
On the first visit
eGFR, mL/min/1.73m2 104.4 (69.9–125.0) 16.1 99.3 (27.7–237.0) 83.0 87.2 (34.6–156.0) 94.1 (16.1–237.0)
SNHL, % (n) 0 0 3 (1) 100 (1) 7 (1) 6 (3)
Nephrocalcinosis, % (n) 100 (4) 100 (1) 21 (6/29) 100(1) 83 (5/6) 41 (17/41)
On the last visit
eGFR, ml/min/1.73m2 76.6 (74.5–80.8) 63.3 107.6 (5.0–164.0) 88.6 106.1 (17.0–211.8) 103.9 (5.0–211.8)
Impaired kidney function, % (n) 0 (0) 0 12 (4) 0 (0) 13 (2) 11 (6)
SNHL, % (n) 0 0 6 (2) 100 (1) 7 (1) 7 (4)
Nephrocalcinosis, % (n) 100 (4) 100 (1) 13 (3/24) 100(1) 46 (6/13) 35 (15/43)
Developmental delay, % (n) 25 (1) 0 12 (4) 100 (1) 13 (2) 15 (8)

BS, Bartter syndrome; GA, gestational age; eGFR, estimated glomerular filtration rate [calculated using the bedside Schwartz equation for children and CKD-EPI equation for adults]; Impaired kidney function, defined as an eGFRcr < 60 mL/min/1.73 m2; SNHL, Sensorineural hearing loss.